Average tumor masses for each group showed the same pattern, with statistical analysis revealing that the only treatment significantly different from untreated control was the dual treatment group (IFN-γ plus sunitinib, p < 05); single treatments were not significantly different from control (Figure 7(b), right panel). This evidence concerns the gene IFNG and neoplasm.